ADC Therapeutics (ADCT) Inventory Average (2022 - 2026)

ADC Therapeutics has disclosed Inventory Average across 4 years of filings, most recently posting $4.5 million for Q1 2026.

• Inventory Average for Q1 2026 came in at $4.5 million, down 54.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.5 million (down 54.51% YoY), and the FY2025 annual result was $3.2 million, down 65.08% from the prior year.
• Inventory Average came in at $4.5 million for Q1 2026 at ADC Therapeutics, down from $11.1 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $17.9 million in Q3 2025 to a low of $4.5 million in Q1 2026.
• The 4-year median for Inventory Average is $13.6 million (2022), against an average of $12.9 million.
• Across the five-year window, Inventory Average increased 21.3% in 2025 and tumbled 54.51% in 2026, its largest moves.
• ADC Therapeutics' Inventory Average stood at $11.6 million in 2022, then slipped by 21.0% to $9.2 million in 2024, then gained by 21.3% to $11.1 million in 2025, then plunged by 59.69% to $4.5 million in 2026.
• The last three Inventory Average figures came in at $4.5 million (Q1 2026), $11.1 million (Q4 2025), and $17.9 million (Q3 2025), per Business Quant data.